DSV, 622 - Registration of share capital increase completed

Udgivet den 23-11-2015  |  kl. 10:21  |  

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Company announcement no. 622

Registration of share capital increase completed

We refer to our company announcement no. 621 of 18 November 2015.

DSV A/S (“DSV) has in connection with the private placement today completed and registered the capital increase with the Danish Business Authority of a nominal value DKK 17,499,999 (17,499,999 shares of a nominal value of DKK 1.00 each), representing 9.99% of the share capital prior to the capital increase.

The new shares will be listed under ISIN code DK0060079531 for DSV’s existing shares on Nasdaq Copenhagen with effect from 24 November 2015.

Questions may be addressed to IR Director Flemming Ole Nielsen on +45 43 20 33 92.

Yours sincerely,

DSV

 

IMPORTANT DISCLAIMER

This announcement is not a prospectus and investors should not purchase any securities referred to in this announcement on the basis of this announcement. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purposes whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. The information in this announcement is subject to change. No obligation is undertaken to update this announcement or to correct any inaccuracies, and the distribution of this announcement shall not be deemed to be any form of commitment on the part of the Company to proceed with any transaction or arrangement referred to herein. This announcement has not been approved by any competent regulatory authority.

This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any shares or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with or act as an inducement to enter into, any contract or commitment whatsoever. The transactions described in this announcement and the distribution of this announcement and other information in connection with the transactions in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

In particular, this announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States, Australia, Canada, South Africa or Japan, or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States except to qualified institutional buyers as defined in, and in reliance on, Rule 144A under U.S. Securities Act of 1933 as amended (the Securities Act) or another applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States, Australia, Canada, South Africa or Japan or to make a public offering of the securities in the United States.

This announcement has been prepared on the basis that any offers of securities referred to herein in any Member State of the EEA will be made pursuant to an exemption under the Prospectus Directive from the requirement to publish a prospectus for offers of such securities. The information set forth in this announcement is only being distributed to, and directed at, persons in Member States of EEA which have implemented the Prospectus Directive (Directive No. 2003/71/EC and amendments thereto, including Directive No. 2010/73/EU, to the extent implemented in the relevant Member State) who are qualified investors (“Qualified Investors”) within the meaning of Article 2(1)(e) of the Prospectus Directive. In addition, in the United Kingdom, this information is only being distributed to, and is only directed at, (x) Qualified Investors who are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (y) high net worth entities falling within Article 49(2)(a)-(d) of the Order, or (z) persons to whom it may otherwise lawfully be communicated.

None of the Company, the Managers or any of their respective subsidiary undertakings, affiliates or any of their respective directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

This announcement does not constitute an investment recommendation. The price and value of securities and any income from them can go down as well as up and you could lose your entire investment. Past performance is not a guide to future performance. Information in this announcement cannot be relied upon as a guide to future performance.

Vedhæftede filer:

622 - Announcement (23.11.2015) - Registration of share capital increase completed.pdf

Udgivet af: NPinvestordk

Seneste nyheder

11:43 Aktier/middag: GN og Zealand op på analysenyt - banker tynges af udsigt til lavere renter
10:50 GN får købsanbefaling hos Jyske Bank efter store kursfald
10:18 Zealand Pharma løftes til "hold": Danske Bank afventer nyt om Novos arvtager
09:54 Kina præsenterer nyt tiltag til at pumpe liv i svækket økonomi
09:50 Zealand sidder med stort potentiale på hånden: JPMorgan indleder med "overvægt"
09:37 Chemometec får smilene frem hos investorerne efter regnskab
09:27 Sony opjusterer efter stærkt musik- og spilsalg
09:20 Zealand Pharma får løftet anbefalingen til "hold" hos Danske Bank
09:16 Torm får reduceret endnu et kursmål efter nedjustering
09:11 Aktier/åbning: Zealand topper grøn start for C25 - Vestas atter i bunden
08:44 Obligationer/åbning: Renterne slår kontra og tager lille stigning fra start
08:38 Ørsted får sænket kursmålet hos Arctic
08:34 Råvarer: Oliepriserne på vej mod ugentlig stigning trods dyk
08:24 Vestas får skåret yderligere i suverænt laveste kursmål - sænkes til 80 kr. af Barclays
08:21 Novo får skåret kursmålet til 772 kr. fra 855 kr. af tysk finanshus
08:20 Mere positivt nyt til Mærsk: Rateindeks fortsætter i positivt spor
08:19 Aktier/tendens: Vestas får flere kursmålsklø før ventet lysegrøn start
07:50 Japansk Ambu-konkurrent imponerer med overskuddet i andet kvartal
07:46 Chemometec får løftet anbefaling til "hold" fra "sælg" hos Nordea
07:28 Vestas får sænket kursmålet til 80 kr. fra 99 kr. af Barclays